These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 31722345)
21. Effect of Tumor Location on the Risk of Bilateral Central Lymph Node Metastasis in Unilateral 1-4 cm Papillary Thyroid Carcinoma. Liu N; Chen B; Li L; Zeng Q; Sheng L; Zhang B; Lv B Cancer Manag Res; 2021; 13():5803-5812. PubMed ID: 34321927 [TBL] [Abstract][Full Text] [Related]
22. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer. Zhao H; Li H; Huang T J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201 [TBL] [Abstract][Full Text] [Related]
23. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165 [TBL] [Abstract][Full Text] [Related]
24. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Zhan J; Diao X; Chen Y; Wang W; Ding H Clin Hemorheol Microcirc; 2019; 72(1):61-73. PubMed ID: 30452407 [TBL] [Abstract][Full Text] [Related]
25. Risk factors for central lymph node metastasis in papillary thyroid carcinoma: A National Cancer Data Base (NCDB) study. Suman P; Wang CH; Abadin SS; Moo-Young TA; Prinz RA; Winchester DJ Surgery; 2016 Jan; 159(1):31-9. PubMed ID: 26435436 [TBL] [Abstract][Full Text] [Related]
26. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. Nie X; Tan Z; Ge M BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029 [TBL] [Abstract][Full Text] [Related]
27. Shorter distance between the nodule and capsule has greater risk of cervical lymph node metastasis in papillary thyroid carcinoma. Wang QC; Cheng W; Wen X; Li JB; Jing H; Nie CL Asian Pac J Cancer Prev; 2014; 15(2):855-60. PubMed ID: 24568507 [TBL] [Abstract][Full Text] [Related]
28. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China. Xue S; Wang P; Liu J; Li R; Zhang L; Chen G Asian J Surg; 2016 Jul; 39(3):131-6. PubMed ID: 26117203 [TBL] [Abstract][Full Text] [Related]
29. Influence of Obesity Parameters on Different Regional Patterns of Lymph Node Metastasis in Papillary Thyroid Cancer. Wu WX; Feng JW; Ye J; Qi GF; Hong LZ; Hu J; Liu SY; Jiang Y; Qu Z Int J Endocrinol; 2022; 2022():3797955. PubMed ID: 36389127 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis. Yan B; Hou Y; Chen D; He J; Jiang Y Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280 [TBL] [Abstract][Full Text] [Related]
31. Magnetic Resonance Imaging Characteristics of Papillary Thyroid Carcinoma for the Prediction of Cervical Central Compartment Lymph Node Metastasis. Wang H; Liu K; Ren J; Liu W; Chen Y; Song B J Comput Assist Tomogr; 2019; 43(6):963-969. PubMed ID: 31162232 [TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346 [TBL] [Abstract][Full Text] [Related]
33. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma. Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850 [TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases. Zhao H; Li H Eur J Radiol; 2019 Mar; 112():14-21. PubMed ID: 30777203 [TBL] [Abstract][Full Text] [Related]
35. Fasting serum glucose and lymph node metastasis in non-diabetic PTC patients: a 10-Year multicenter retrospective study. Liu Y; Gong J; Huang Y; Xing S; Chen L; Yi T; Wang Z; Lv Y J Cancer; 2022; 13(8):2673-2682. PubMed ID: 35711846 [No Abstract] [Full Text] [Related]
36. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma. Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. Deng L; Song Y; Young KH; Hu S; Ding N; Song W; Li X; Shi Y; Huang H; Liu W; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Ying Z; Zhang C; Sun Y; Zhu J Oncotarget; 2015 Sep; 6(28):25061-73. PubMed ID: 26314957 [TBL] [Abstract][Full Text] [Related]
38. Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy. Huang J; Song M; Shi H; Huang Z; Wang S; Yin Y; Huang Y; Du J; Wang S; Liu Y; Wu Z Front Oncol; 2021; 11():574774. PubMed ID: 34094896 [TBL] [Abstract][Full Text] [Related]
39. RANKL, OPG, TRAIL, KRas, and c-Fos expression in relation to central lymph node metastases in papillary thyroid carcinoma. Deligiorgi MV; Mahaira H; Eftychiadis C; Kafiri G; Georgiou G; Theodoropoulos G; Konstadoulakis MM; Zografos E; Zografos GC J BUON; 2018; 23(4):1029-1040. PubMed ID: 30358208 [TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma]. Yue C; Zhang Y; Xing L; Zhao Y; Chen J; Jin Y; Liu H Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3637-41. PubMed ID: 25622954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]